Ursolic acid ameliorates thymic atrophy and hyperglycemia in streptozotocin–nicotinamide-induced diabetic mice (Q42876761)

9 November 2017

title

Ursolic acid ameliorates thymic atrophy and hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice (English)

1 reference

9 November 2017

Ursolic acid ameliorates thymic atrophy and hyperglycemia in streptozotocin–nicotinamide-induced diabetic mice (English)

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

20 July 2024

1 reference

Jin Lee

1

1 reference

9 November 2017

Sung-Tae Yee

2

1 reference

9 November 2017

Jong-Jin Kim

3

1 reference

9 November 2017

Myung-Sook Choi

4

1 reference

9 November 2017

Eun-Young Kwon

5

1 reference

9 November 2017

Kwon-Il Seo

6

1 reference

9 November 2017

Mi-Kyung Lee

7

1 reference

9 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20869956

20 July 2024

publication date

24 September 2010

1 reference

full work available at URL

9 November 2017

https://api.elsevier.com/content/article/PII:S000927971000565X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

https://api.elsevier.com/content/article/PII:S000927971000565X?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Chemico-biological Interactions

20 July 2024

published in

1 reference

9 November 2017

volume

188

1 reference

9 November 2017

issue

3

1 reference

9 November 2017

page(s)

635-642

1 reference

Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population

9 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Clinical characteristics of Korean type 2 diabetic patients in 2005.

20 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Hepatocytes: critical for glucose homeostasis

20 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Metformin blunts stress-induced hyperglycemia after thermal injury

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

THE NATURE OF THE LOWERED RESISTANCE TO INFECTION IN DIABETES MELLITUS.

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Glucose metabolism in lymphoid and inflammatory cells and tissues.

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Endothelial dysfunction in normal and abnormal glucose metabolism

20 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake

20 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet

20 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice

20 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Mechanism by which metformin reduces glucose production in type 2 diabetes

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes

20 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.

20 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Report of the American Institute of Nurtition ad hoc Committee on Standards for Nutritional Studies

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome

20 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus: effects on the B-cell mass, insulin content and fibrosis in the pancreas.

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

20 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Maturational impairment of thymic lymphocytes in streptozotocin-induced diabetes in rats

20 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Streptozotocin effects on T lymphocytes and bone marrow cells

20 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Definition of streptozocin toxicity for primary lymphoidal tissues

20 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

The role of T-cell subsets and cytokines in the regulation of infection

20 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Aqueous extracts from dietary supplements influence the production of inflammatory cytokines in immortalized and primary T lymphocytes

20 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes.

20 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Innate immunity, insulin resistance and type 2 diabetes.

20 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.

20 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Correlations of sleep disturbance with the immune system in type 2 diabetes mellitus.

20 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Effects of a diabetes-like environment in vitro on cytokine production by mouse splenocytes

20 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages

20 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate

20 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Thymic microenvironmental alterations in experimentally induced diabetes

20 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Thymus involution in alloxan diabetes: analysis of mast cells

20 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Protective effects of a calcium channel blocker on apoptosis in thymus of neonatal STZ-diabetic rats

20 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Ultrastructure of the thymus in diabetes mellitus and starvation

20 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

The thymus is a common target organ in infectious diseases

20 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Thymic alterations in Plasmodium berghei-infected mice.

20 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision

20 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Cytokines, leptin, and stress-induced thymic atrophy

20 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Leptin action in the thymus

20 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

The thymus is a common target in malnutrition and infection

20 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

The role of leptin in innate and adaptive immune responses

20 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Survival Benefits of Intensive Insulin Therapy in Critical Illness: Impact of Maintaining Normoglycemia Versus Glycemia-Independent Actions of Insulin

20 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats

20 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Effects of fasting on tissue glucose utilization in conscious resting rats. Major glucose-sparing effect in working muscles.

20 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Pharmacology of oleanolic acid and ursolic acid

20 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats

20 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

Ursolic acid: an anti- and pro-inflammatory triterpenoid

20 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.09.019

20 July 2024

Identifiers

1 reference

9 November 2017

1 reference